HB5226

Michigan HB5226 requires health insurance policies in Michigan to cover treatment for pediatric autoimmune neuropsychiatric disorders.

Michigan HB5226 amends the state's insurance laws to mandate coverage for pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute-onset neuropsychiatric syndrome. This includes coverage for treatments such as intravenous immunoglobulin therapy. The requirement applies to health insurance policies delivered, issued, or renewed in Michigan, or to policies covering Michigan residents regardless of where they are issued, starting 90 days after the bill's enactment.